A lipid membrane-centric role of the SQSTM1/p62 body during autophagosome formation

Autophagy. 2024 May;20(5):1192-1193. doi: 10.1080/15548627.2023.2297622. Epub 2024 Jan 1.

Abstract

The phase separated SQSTM1/p62 body drives the formation of autophagosomes during macroautophagy/autophagy. However, the underlying mechanism by which the SQSTM1/p62 body acts during this process remains less understood. Recently, we reported that the SQSTM1/p62 body can work as a nucleation center to recruit local membrane sources for the expanding phagophore. Proteomics analysis reveals membrane vesicle-related components as important constituents of the SQSTM1/p62 body. ATG9- and ATG16L1-positive vesicles are recruited by the SQSTM1/p62 body as initial membrane sources of phagophores. ATG2 promotes the lipid transfer and vesicle fusion to further expand the membrane architecture of the initial phagophore. The lipid composition and content within the SQSTM1/p62 body is significantly affected by ATG2. The SQSTM1/p62 body also regulates the proper positioning and abundance of ATG9-positive vesicles. Furthermore, by spatially gathering ULK1 and membrane-anchored class III phosphatidylinositol (PtdIns) 3-kinase complexes, the SQSTM1/p62 body acts a local reaction platform to generate PtdIns-3-phosphate (PtdIns3P) to accelerate autophagosome maturation. These findings highlight a lipid membrane gathering model of the multifaceted SQSTM1/p62 body when driving autophagosome formation.

Keywords: ATG2; ATG9; autophagy; lipid; membrane; p62.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagosomes* / metabolism
  • Autophagy* / physiology
  • Autophagy-Related Proteins / metabolism
  • Humans
  • Membrane Lipids / metabolism
  • Sequestosome-1 Protein* / metabolism

Substances

  • Sequestosome-1 Protein
  • Membrane Lipids
  • SQSTM1 protein, human
  • Autophagy-Related Proteins

Grants and funding

This work was supported by Xinjiang Uygur Autonomous Region Tianshan Talent Training Program [2022TSYCCX0030] and State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia [SKL-HIDCA-2023-5], the National Natural Science Foundation of China [31771536 and 31860316], to N.M.